一个自上而下的设计方法,用于生成一个质PROTAC药物向雄激素受体,用于雄激素脱发治疗
Bohan Ma1, Donghua Liu1, Zhe Wang2
1Department of Urology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710049, China.
Journal of medicinal chemistry
|June 5, 2024
概括
这项研究引入了一种使用人工智能开发的基于酸的新型蛋白质溶解向奇美拉 (PROTAC) 药物开发方法. 该方法成功设计和验证了PROTACs用于治疗雄激素脱发症,证明了药物发现的实际应用.
科学领域:
- 生物化学 生物化学
- 计算生物学 计算生物学
- 药物开发 药物开发
背景情况:
- 人工智能 (AI) 模型正在推进蛋白质结构预测和设计.
- 翻译深度学习模型用于宏分子药物开发面临局限性.
研究的目的:
- 为了弥合蛋白质科学中的AI和实际药物开发之间的差距.
- 建立一种基于的新型蛋白质溶解向奇美拉 (PROTAC) 药物开发范式.
主要方法:
- 利用ProteinMPNN和RF扩散来识别与雄激素受体 (AR) 和Von Hippel-Lindau (VHL) 相结合的.
- 使用Alphafold2-multimer和ZDOCK进行空间相互关系的计算建模.
- 集成的透皮微针贴片用于药物输送.
主要成果:
- 成功识别了与AR和VHL结合的.
- 实验验证了设计的的结合能力.
- 在安卓脱发症的通过皮肤输送系统中成功应用.
结论:
- 开发了一种生成PROTACs的通用方法.
- 展示了一种针对雄激素脱发症的实用治疗药物设计.
- 强调了跨学科方法在推进个性化医学的潜力.
相关概念视频
01:28Structure-Activity Relationships and Drug Design
699
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
699
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K